Probing the Tasmanian Devil Serum Proteome for Preclinical Diagnosis of Devil Facial Tumour Disease

探索塔斯马尼亚恶魔血清蛋白质组用于恶魔面部肿瘤疾病的临床前诊断

• 批准号: LP0776804
• 负责人: Prof Michael Breadmore
• 金额: $ 4.1万
• 依托单位: University of Tasmania
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2007
• 资助国家: 澳大利亚
• 起止时间: 2007-01-01 至 2008-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0776804
• 关键词: Probing; Tasmanian; Devil; Serum; Proteome

The Tasmanian Devil (Sarcophilus harrisii) is a carnivorous marsupial endemic to the island state of Tasmania, and is found all over the state. Over the past decade, a dramatic decline has occurred in the Devil population in association with the emergence of Devil Facial Tumour Disease (DFTD). This project aims to develop a preclinical diagnostic test for DFTD that will provide vital information for use in developing management strategies to ensure the ongoing survival of the Tasmanian Devil. The benefit to Australia in performing this research rests in the new technology that will be developed and the application of this technology to key areas of national and international significance.

塔斯马尼亚魔鬼（学名：Sarcophilus harrisii）是塔斯马尼亚岛特有的食肉有袋类动物，在整个塔斯马尼亚州都有发现。在过去的十年中，与魔鬼面部肿瘤病（DFTD）的出现有关的魔鬼人口急剧下降。该项目旨在为DFTD开发一种临床前诊断测试，为制定管理策略提供重要信息，以确保塔斯马尼亚魔鬼的持续生存。澳大利亚进行这项研究的好处在于将开发新技术，并将这项技术应用于具有国家和国际意义的关键领域。